Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Lymphocytic, Chronic, B-Cell × olaparib × 30 days × Clear all

Sponsor

Conditions

Ovarian Neoplasms 15 Fallopian Tube Neoplasms 11 Triple Negative Breast Neoplasms 7 Breast Neoplasms 6 Neoplasms 4 Endometrial Neoplasms 4 Prostatic Neoplasms 3 Pancreatic Neoplasms 3 Neoplasm Metastasis 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Multiple Myeloma 2 Metastatic Castration-resistant Prostate Cancer 2 Lymphoma, Non-Hodgkin 2 Glioma 2 Glioblastoma 2 Carcinoma 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Solid Tumors 1 Sarcoma 1 Recurrent Ovarian High Grade Serous Adenocarcinoma 1 Recurrence 1 Prostatic Neoplasms, Castration-Resistant 1 Pheochromocytoma 1 Pathologic Complete Response 1 Paraganglioma 1 Osteosarcoma 1 Inflammatory Breast Neoplasms 1 High Grade Serous Carcinoma 1

Interventions

venetoclax 23 ibrutinib 13 Rituximab 13 Cyclophosphamide 13 obinutuzumab 10 fludarabine 9 pirtobrutinib 8 Specimen Handling 7 zanubrutinib 6 Biopsy 6 Bendamustine Hydrochloride 6 acalabrutinib 5 fludarabine phosphate 4 Whole-Body Irradiation 4 Prednisone 4 Lenalidomide 4 Vincristine 3 Mycophenolic Acid 3 Magnetic Resonance Spectroscopy 3 Doxorubicin 3 CT-P10 3 idelalisib 2 Tacrolimus 2 Surveys and Questionnaires 2 Granulocyte Colony-Stimulating Factor 2 Cyclosporine 2 Chlorambucil 2 ARQ531 2 voruciclib 1 treosulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡